HIPK2 is considered to be a potential haplo-insufficient tumour suppressor as it can promote apoptosis in response to chemotherapeutic drugs and radiation, mainly by phosphorylating p53 at S46,1, 21 which then induces expression of pro-apoptotic genes. The gene discussed is TP53; the disease is neoplasm.